ERBB2 and metastatic malignant neoplasm in the lymph nodes: Consequently, treatments are selected based on ER/PR/human epidermal growth factor receptor 2 (HER2) expression status, tumor size and grade, lymph node metastasis (LNM), and distant metastasis (DM) (Chlebowski and Anderson, 2012).